Studies have demonstrated the neuroprotective effect of cannabidiol (CBD) and other
Cannabis sativa L. derivatives on diseases of the central nervous system caused by their …

Background: Cannabidiol (CBD) is among the major secondary metabolites of Cannabis
devoid of the delta-9-tetra-hydrocannabinol psychoactive effects. It is a resorcinol-based …

Despite the introduction of new antiepileptic drugs (AEDs), the quality of life and therapeutic
response for patients with epilepsy remains still poor. Unfortunately, besides several …

Cannabinoids' usefulness in the treatment of neurological disorders (epilepsy, and various
neurodegenerative diseases, such as Multiple Sclerosis and Alzheimer's Disease) has been …

Background: Starting from the chemical structure of phytocannabinoids, isolated from
Cannabis sativa plant, research groups designed numerous cannabimimetic drugs. These …

The pharmacological research on the Cannabis sativa-derived compounds has never
terminated. Among the phytocannabinoids without psychotropic effects, the prevalent one in …

This work is a literature review, presenting the current state of the use of cannabinoids on
neurodegenerative diseases. The emphasis is on Parkinson's (PD) and Alzheimer's (AD) …

Although cannabis has been known for ages as an “alternative medicine” to provide relief
from seizures, pain, anxiety, and inflammation, there had always been a limited scientific …

Purpose of review There have been many debates, discussions, and published writings
about the therapeutic value of cannabis plant and the hundreds of cannabinoids it contains …

Nowadays, Cannabis sativa is considered the most extensively used narcotic. Nevertheless,
this fame obscures its traditional employ in native medicine of South Africa, South America …